Our Mission is to Revolutionize Immunotherapy Through Advanced Genetic Engineering, Committed Expertise, and Groundbreaking Research for a Future Free from Lung Cancer.
Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam.
Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam.
Meet Our Founders
Dr. Alexandre Reuben, Ph.D.
Assistant Professor of Thoracic/Head & Neck Medical Oncology, MD Anderson
Dr. Reuben is an immunologist and T cell biologist who has been studying anti-tumor T cell responses for over 15 years. Dr. Reuben leads a cell therapy and T cell engineering lab at MD Anderson. Dr. Reuben’s lab has developed an ultra-sensitive T cell receptor discovery platform and validated a set of T cell receptors targeting some of the most prevalent antigens in lung cancer and solid tumors.
Assistant Professor, of Thoracic/Head & Neck Medical Oncology, MD Anderson
Dr. Reuben is an immunologist and T cell biologist who has been studying anti-tumor T cell responses for over 15 years. Dr. Reuben leads a cell therapy and T cell engineering lab at MD Anderson. Dr. Reuben’s lab has developed an ultra-sensitive T cell receptor discovery platform and validated a set of T cell receptors targeting some of the most prevalent antigens in lung cancer and solid tumors. Dr. Reuben is an inventor on more than 15 patents pertaining to cellular therapy and novel methodologies.
Dr. John V. Heymach, M.D., Ph.D.
Chair and Professor of Thoracic/Head & Neck Medical Oncology, MD Anderson
Dr. Heymach is a physician-scientist and thoracic oncologist at MD Anderson. Dr. Heymach leads a research lab focused on investigating mechanisms of therapeutic resistance in order to develop innovative therapies for the treatment of lung cancer. Dr. Heymach has won numerous prestigious awards and has served as principal investigator on several impactful clinical trials over the last 2 decades.
Transformative Solutions in Lung Cancer Treatment
Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam.
what we are
hoping to do
Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus.
solid tumors
Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam.Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam.
T cell receptor engineering
Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam.Pretium urna ultrices integer augue feugiat hendrerit. Varius non consectetur mauris nisi a vel ut sed diam. Orci at sollicitudin placerat sed quis. Dolor odio egestas imperdiet nulla rhoncus. Ante eu commodo sem mi dis. Rutrum nam.
